Physician
Medstar Medical Group - Southern Maryland LLC
Medstar Medical Group - Southern Maryland LLC was paid $27.72M by Medicaid between Jan 2018 and Dec 2024, across 190 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoMEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC
HOLLYWOOD, MD 20636
HOLLYWOOD, MD 20636
33aNPI1831592211assigned 09/30/2014
33bProvider typeDermatology Physician
28Total paid$27.72M
24GClaims545,735
24DCodes billed190
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Dermatology Physician providers in Maryland
Rank by total paid#1 of 36
Median peer was paid$45K
This provider vs. median609×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,761 | $1.67M | |
| 2019 | 23,676 | $1.06M | |
| 2020 | 81,341 | $3.41M | |
| 2021 | 99,716 | $4.60M | |
| 2022 | 106,180 | $5.48M | |
| 2023 | 116,821 | $6.23M | |
| 2024incomplete | 95,240 | $5.27M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 150,215 | 128,628 | $12.67M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 87,687 | 76,592 | $5.68M |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 3.7% | 6,189 | 5,801 | $1.03M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.9% | 9,131 | 8,473 | $806K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.1% | 5,145 | 4,298 | $591K |
| 36415 | Collection of venous blood by venipuncture | 1.8% | 52,257 | 45,810 | $505K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.4% | 3,893 | 3,487 | $379K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.3% | 6,251 | 5,701 | $352K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.1% | 3,106 | 2,872 | $310K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 3,435 | 2,769 | $298K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 4,468 | 3,768 | $297K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,153 | 1,907 | $233K |
178 more codes
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 7,316 | $227K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,934 | $198K |
| 99223 | Prolong inpt eval add15 m | <1% | 3,596 | $195K |
| 88342 | <1% | 2,891 | $193K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 1,354 | $180K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 3,880 | $170K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 5,808 | $167K |
| 88313 | <1% | 2,666 | $166K | |
| 93000 | <1% | 7,948 | $164K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 29,475 | $139K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,169 | $136K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 2,151 | $104K |
| 99243 | <1% | 931 | $98K | |
| 90686 | <1% | 5,096 | $95K | |
| 88312 | <1% | 1,323 | $94K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,564 | $77K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 8,539 | $72K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 920 | $71K |
| 88341 | <1% | 824 | $71K | |
| 92551 | <1% | 8,145 | $70K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 1,130 | $69K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,496 | $63K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 593 | $59K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,534 | $56K |
| 76536 | <1% | 634 | $55K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 12,297 | $55K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 521 | $51K |
| 99401 | <1% | 5,406 | $50K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 954 | $49K |
| 76830 | Ultrasound, transvaginal | <1% | 526 | $48K |
| 46221 | <1% | 213 | $44K | |
| 93015 | <1% | 1,416 | $43K | |
| 90670 | <1% | 2,028 | $40K | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,497 | $40K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,976 | $40K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,120 | $39K |
| 99406 | <1% | 2,880 | $39K | |
| 90648 | <1% | 1,918 | $37K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,399 | $36K |
| 95886 | <1% | 286 | $33K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 711 | $32K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | <1% | 75 | $31K |
| 90677 | <1% | 373 | $31K | |
| 76641 | <1% | 336 | $31K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,599 | $30K |
| 95911 | <1% | 203 | $30K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,024 | $27K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 2,449 | $25K |
| 90723 | <1% | 1,259 | $24K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,135 | $24K |
| 81025 | <1% | 4,407 | $24K | |
| 90633 | <1% | 1,126 | $22K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,466 | $22K |
| 99442 | <1% | 1,254 | $22K | |
| 90461 | <1% | 5,575 | $20K | |
| 90651 | <1% | 827 | $18K | |
| 99173 | <1% | 7,911 | $18K | |
| 96127 | <1% | 4,227 | $17K | |
| 45384 | <1% | 103 | $17K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,063 | $15K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 152 | $15K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 374 | $15K |
| 90734 | <1% | 673 | $14K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 808 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 192 | $13K |
| 99443 | <1% | 515 | $12K | |
| 99205 | Prolong outpt/office vis | <1% | 194 | $12K |
| 80061 | Lipid panel | <1% | 1,084 | $12K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 1,099 | $12K |
| 99495 | <1% | 92 | $12K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 512 | $11K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,562 | $11K |
| 45381 | <1% | 129 | $11K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 1,483 | $11K |
| 90674 | <1% | 465 | $10K | |
| 90680 | <1% | 544 | $10K | |
| 90716 | <1% | 489 | $10K | |
| 00813 | <1% | 112 | $10K | |
| 90961 | <1% | 1,083 | $9K | |
| 76770 | <1% | 106 | $9K | |
| 90707 | <1% | 444 | $9K | |
| 72100 | <1% | 312 | $9K | |
| 90653 | <1% | 296 | $8K | |
| 64615 | <1% | 56 | $8K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 209 | $8K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 12 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 866 | $7K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 256 | $7K |
| W7000 | <1% | 1,444 | $7K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 101 | $7K |
| 71250 | <1% | 65 | $6K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 46 | $6K |
| 00731 | <1% | 177 | $5K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 491 | $5K |
| 87807 | <1% | 475 | $5K | |
| 75574 | <1% | 18 | $5K | |
| 90694 | <1% | 515 | $5K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 86 | $4K |
| 99385 | <1% | 40 | $4K | |
| 90715 | <1% | 192 | $4K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 137 | $4K |
| 87081 | <1% | 1,022 | $4K | |
| 94060 | <1% | 202 | $4K | |
| 73562 | <1% | 159 | $3K | |
| 99441 | <1% | 293 | $3K | |
| 0012A | <1% | 76 | $3K | |
| 45390 | <1% | 13 | $3K | |
| 43248 | <1% | 26 | $3K | |
| 99217 | <1% | 39 | $3K | |
| 96160 | <1% | 1,249 | $3K | |
| 20553 | <1% | 67 | $3K | |
| 00812 | <1% | 29 | $3K | |
| 82962 | <1% | 1,023 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 355 | $2K |
| 99050 | <1% | 345 | $2K | |
| 97802 | <1% | 32 | $2K | |
| 94726 | <1% | 52 | $2K | |
| 94729 | <1% | 52 | $2K | |
| 99254 | <1% | 13 | $2K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 74 | $2K |
| 99497 | <1% | 315 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 88 | $2K |
| 84439 | <1% | 283 | $2K | |
| 90620 | <1% | 64 | $2K | |
| 90656 | <1% | 91 | $2K | |
| 71271 | <1% | 12 | $2K | |
| 90696 | <1% | 74 | $2K | |
| 73620 | <1% | 52 | $1K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 22 | $1K |
| 36416 | <1% | 1,297 | $1K | |
| 73130 | <1% | 50 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 16 | $1K |
| 90732 | <1% | 59 | $1K | |
| 99381 | <1% | 13 | $1K | |
| 95251 | <1% | 27 | $912.62 | |
| G0008 | Administration of influenza virus vaccine | <1% | 1,549 | $897.31 |
| 0011A | <1% | 32 | $884.70 | |
| 0072A | <1% | 26 | $880.00 | |
| 90662 | <1% | 108 | $862.47 | |
| 90647 | <1% | 43 | $839.00 | |
| 73630 | <1% | 34 | $743.11 | |
| 94618 | <1% | 28 | $684.62 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 24 | $653.79 |
| 0071A | <1% | 16 | $600.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 33 | $581.24 |
| 80050 | General health panel | <1% | 12 | $562.50 |
| 99221 | <1% | 14 | $506.75 | |
| 77080 | <1% | 12 | $490.71 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 90 | $479.43 |
| 86140 | <1% | 88 | $411.48 | |
| 73560 | <1% | 17 | $370.85 | |
| 00811 | <1% | 16 | $302.70 | |
| 85651 | <1% | 119 | $299.28 | |
| 96161 | <1% | 104 | $269.12 | |
| 90700 | <1% | 17 | $256.08 | |
| H0049 | Alcohol and/or drug screening | <1% | 295 | $255.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 45 | $213.84 |
| G0443 | Brief face-to-face behavioral counseling for alcohol misuse, 15 minutes | <1% | 12 | $200.21 |
| 84100 | <1% | 54 | $158.10 | |
| 83735 | <1% | 57 | $144.54 | |
| 81002 | <1% | 88 | $136.52 | |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 21 | $119.34 |
| 81000 | <1% | 62 | $115.47 | |
| 81003 | <1% | 73 | $101.56 | |
| 20610 | <1% | 19 | $97.61 | |
| 93290 | <1% | 37 | $88.70 | |
| 84436 | <1% | 21 | $74.14 | |
| 81001 | <1% | 27 | $71.82 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 37 | $46.58 |
| 90962 | <1% | 12 | $41.09 | |
| 99080 | <1% | 97 | $40.00 | |
| 91301 | <1% | 200 | $0.16 | |
| 91307 | <1% | 40 | $0.01 | |
| G0009 | Administration of pneumococcal vaccine | 0% | 166 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 13 | $0.00 |
| 99490 | Ccm add 20min | 0% | 20 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 38 | $0.00 |
| 98960 | 0% | 22 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWAGNER, ERIC (EXECUTIVE VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Medstar Medical Group - Southern Maryland LLC | Waldorf, MD | $283K |
| Medstar Health Anesthesia Services B, LLC | Baltimore, MD | $4K |
| Medstar Health Anesthesia Services A, LLC | Baltimore, MD | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.